Skip to main content
. 2019 Feb 15;35(3):489–495. doi: 10.1007/s12288-019-01092-y

Fig. 2.

Fig. 2

Thrombophilic risk factors in controls and patients of venous thromboembolism. APL Ab anti phospholipid antibody, FVL factor V Leiden, PS def Protein S deficiency, AT def antithrombin deficiency and PC def Protein C deficiency